Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
National Institute of Mental Health (NIMH) |
---|---|
Information provided by: | National Institute of Mental Health (NIMH) |
ClinicalTrials.gov Identifier: | NCT00046085 |
This study will evaluate the benefits of providing families of schizophrenia patients the opportunity to interact with each other using the Internet.
Condition | Intervention |
---|---|
Schizophrenia |
Behavioral: Family Psychoeducational Program |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study |
Official Title: | Online Family Support and Education for Schizophrenia |
Estimated Enrollment: | 72 |
Study Start Date: | March 2001 |
Although psychoeducational programs for schizophrenia can reduce patient relapse rates and reduce family distress, participation rates are often low. This study will provide the families of schizophrenia patients with knowledge of illness management to reduce family burden and increase perceived social support.
Relatives of patients with schizophrenia receive either 18 months of customary care or 18 months of customary care with access to the educational website for the first year. Families are provided with private, secure access to the website, which features family-to-family chat capabilities, video lectures on the management of schizophrenia, written materials on important issues in schizophrenia management, professionally facilitated online discussions of the material, and additional resource links.
Relatives have 90-minute interviews at the beginning of the project and every 6 months for 18 months. The interviews are used to assess the family member's perception of the patient's symptoms, his or her knowledge of the illness, the illness's impact on the family member, and his or her perception of the website intervention.
Patients with schizophrenia or schizoaffective disorder are also asked to complete interviews and assessments at the beginning of the project and every 3 months for 18 months. The assessments include questions about symptoms, medication compliance and side effects, hospitalizations, and social functioning.
Ages Eligible for Study: | 18 Years to 60 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria for Patients:
Inclusion Criteria for Relatives:
Study ID Numbers: | R21 MH62135, DSIR AT-SP |
Study First Received: | September 19, 2002 |
Last Updated: | December 1, 2005 |
ClinicalTrials.gov Identifier: | NCT00046085 |
Health Authority: | United States: Federal Government |
Schizoaffective disorder Diagnosis, Dual (Psychiatry) Psychoeducation Internet |
Schizophrenia Mental Disorders Psychotic Disorders Schizophrenia and Disorders with Psychotic Features |